About Glaucoma Associates of New York
Clinical Trials at Glaucoma Associates of New York
During the past decade, Glaucoma Associates of New York conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Glaucoma Associates of New York" #1 sponsor was "New York Glaucoma Research Institute" with 3 trials, followed by "SOLX, Inc." with 3 trials
sponsored, "Robert Ritch, MD, LLC." with 2 trials sponsored, "Aeon Astron Europe B.V." with 1 trials sponsored and "The New York Eye & Ear Infirmary"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Glaucoma Associates of New York"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Robert Ritch, MD, LLC." with 1 trials as a collaborator and "The New York Eye & Ear Infirmary" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Glaucoma Associates of New York
According to Clinical.Site data, the most researched conditions in "Glaucoma Associates of New York" are
"Glaucoma" (6 trials), "Glaucoma, Open Angle" (3 trials), "Advanced Glaucoma" (1 trials), "Chronic Angle-closure Glaucoma" (1 trials) and "Exfoliation Syndrome" (1 trials). Many other conditions were trialed in "Glaucoma Associates of New York" in a lesser frequency.
Clinical Trials Intervention Types at Glaucoma Associates of New York
Most popular intervention types in "Glaucoma Associates of New York" are "Drug" (6 trials) and "Device" (4 trials). Other intervention types were less common.
The name of intervention was led by "Rho-Kinase Inhibitor" (2 trials), "AR-12286" (1 trials), "Ahmed FP7 Glaucoma Valve" (1 trials), "Argon Laser Trabeculoplasty (ALT)" (1 trials) and "Ranibizumab (Lucentis)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Glaucoma Associates of New York
The vast majority of trials in "Glaucoma Associates of New York" are
11 trials for "All" genders.
Clinical Trials Status at Glaucoma Associates of New York
Currently, there are NaN active trials in "Glaucoma Associates of New York".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Glaucoma Associates of New York,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Glaucoma Associates of New York, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".